Purchase Order HT001423P0041
Award Date
2/13/23
Potential Completion Date
2/9/24
Potential Value
$250K
Federal Agency
Defense Health Agency
Awardee
Sirtex Medical Inc.
Ultimate Awardee
Not listed
NAICS Category
334517 - Irradiation Apparatus Manufacturing
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded to Sirtex Medical Inc., a for-profit medical device company, by the Defense Health Agency. The contract is for the supply of SIR-Spheres Y-90 radioactive microspheres, which are used in interventional radiology procedures to treat liver tumors and metastatic disease through internal radiation therapy. The contract has a potential value of $17,750.00 and a completion date of August 1, 2022. The contract does not have a set-aside designation. Sirtex...
The Defense Health Agency (DHA) awarded a $177,500.00 firm fixed price purchase order to Sirtex Medical Inc., a for-profit global healthcare company, to provide ten selective internal radiation resin microspheres for the Radiology Department at Walter Reed National Military Medical Center. The microspheres, containing Yttrium-90, are used in selective internal radiation therapy to treat liver tumors and metastatic disease in veterans and military members. This contract award has no set-aside...
This federal contract was awarded by the Department of the Army Medical Command to Sirtex Medical Inc., a global healthcare company that provides medical devices and therapies for cancer treatment. The contract, valued at $709,500.00, is for the delivery of SIR-Spheres Y-90 resin microspheres, which are used in selective internal radiation therapy to treat inoperable liver cancer in veterans and military members. The contract has a firm fixed price and no set-aside designation. Sirtex Medical...
This federal contract award to Sirtex Medical Inc. is for the delivery of SIR-Spheres Y-90 resin microspheres, a medical device used in selective internal radiation therapy to treat inoperable liver cancer. The contract, awarded by the Defense Health Agency, is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $416,000.00. Sirtex Medical, a global healthcare company, is the prime contractor supplying these specialized radioactive spheres to the VA and DOD healthcare systems. The...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Sirtex Medical Inc., a global healthcare company that provides medical devices and therapies for cancer treatment. The contract is for the purchase of Y-90 SIR-Spheres, which are resin microspheres used in selective internal radiation therapy to treat inoperable liver tumors and metastatic disease in veterans and military members. The potential value of the contract is $142,000.00, and it has a...
This is a federal purchase order contract awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc. for the delivery of SIR-Y001 SIR Spheres Y-90 resin microspheres. The $18,345.00 firm fixed-price contract has a period of performance ending on March 31, 2024. The SIR Spheres are used in selective internal radiation therapy to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver, in veterans and military members. This contract has...
This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Sirtex Medical Inc., a for-profit medical device company, to provide SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy used to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver. The contract has a ceiling value of $17,372.00 and does not have a set-aside designation. Sirtex Medical Inc. has a long history of providing these...
This federal contract award to Sirtex Medical Inc., a global healthcare company, is for the supply of SIR-Spheres Y-90 resin microspheres to the Defense Health Agency. The microspheres are used in selective internal radiation therapy to treat inoperable liver cancer in veterans and military members. The firm-fixed-price Blanket Purchase Agreement (BPA) call contract has a potential value of $230,500.00 and a completion date of February 7, 2019. The contract does not have a set-aside designation....
This firm fixed-price purchase order contract was awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc. for the supply of SIR-Spheres Y-90 resin microspheres, a specialized cancer therapy product used for selective internal radiation therapy (SIRT) to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver. The contract has a ceiling value of $37,688.00 and a period of performance through September 30, 2024. Sirtex Medical Inc. is...
This federal contract award, valued at $551,117, was issued by the Defense Health Agency (DHA) to Sirtex Medical Inc., a global healthcare company specializing in innovative cancer therapies. The contract is for the provision of SIR-Spheres Y-90 resin microspheres and associated materials, which are used to treat unresectable metastatic liver tumors from primary colorectal cancer. The contract was awarded as a firm fixed-price purchase order and has been designated as a total small business...